Peter McDonald

Unilever United States, Inc. engages in the manufacture of personal care and consumer products. It distributes laundry detergents, shampoos, ice cream, dinner products, soaps, and body wash under the brand names Axe, Ben & Jerry's, Bertolli, Breyers, Caress, Country Crock, Degree, and Dove. The company was founded 1877 and is headquartered in Englewood Cliffs, NJ.

UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients.

Founded in 1981, Wall Street Access, formerly Wall Street Clearing Corp., is a broker/dealer headquartered in New York City. The firm is a subsidiary of Wall Street Access Corp.. They offer a full array of investment services to corporations, hedge funds, pension funds, trust banks, investment advisors, money managers, mutual funds and high net-worth individuals. They focus on healthcare, mergers & acquisitions, oil & gas, electricity, natural gas, machinery/agribusiness, small-cap equities and special situations sectors. The firm's merger arbitrage research platform enables investors to track both historic and real-time deal information. Wall Street Access offers best-in-class execution through their fixed-income trading platform that creates aggressive, two-sided markets on a large inventory of fixed-income securities. The firm also provides their clients with traditional sales coverage. They provide execution services for investment grade corporate bonds, U.S. Treasuries and U.S. Agencies to a network of over 2,000 global customers. Wall Street Access' approach creates both market transparency and liquidity in a marketplace that has historically not been served with these essentials. The firm seeks to provide best-in-class trade execution and generation of trading ideas. They actively assess and manage risk while executing innovative transactions in a fast-paced and constantly changing global market. Wall Street Access provides superior service, expertise and speedy execution in equities, options, bonds and currencies. The firm seeks to achieve superior execution through electronic connectivity to multiple exchanges combined with their access to significant pools of liquidity. Wall Street Access is an agent, managing trading volumes and finding liquidity in a discrete manner for their institutional clients. The firm's Prime Brokerage division serves small and medium sized hedge fund clients. Wall Street Access maintains a large institutional equity and options desk, as well as a 35-person fixed-income desk. The firm acts as an introducing broker to Goldman Sachs Execution & Clearing LP. , L.P., so your investors can be confident their assets are safe and secure at a leading custodian. Wall Street Access is a member of NYSE, ISE and NASDAQ OMX, as well as other exchanges.

Founded in 2008, WallachBeth Capital LLC is an SEC-registered broker/dealer located in New York City. The firm is an institutional, inter-market-broker providing non-conflicted trade execution and connectivity to the broad spectrum of professional trading market participants and an expansive menu of exchanged-traded products. They specialize in ETFs, listed equity options and index products, OTC derivatives, listed and OTC equities and non-US equities.

Founded in 1989, Harris Nesbitt Gerard, formerly Gerard Klauer Mattison, is an investment bank and broker/dealer located in New York City with additional offices in Boston, Chicago and San Francisco. The firm is a division of BMO Capital Markets (United States) and their ultimate parent is the Bank of Montreal (NYSE, TSX: BMO). Their services include US equity research, sales and trading, equity and debt underwriting, corporate lending/project financing, M&A advisory services, merchant banking and cash management services. Harris Nesbitt Gerard's research focuses on the consumer, healthcare and technology sectors.

Originally founded in 2002 by Curt Snyder and Richard Prati as American Technology Research, Broadpoint.AmTech Equity Capital Markets is an independent research firm and broker/dealer headquartered in Greenwich with offices in Littleton, Colorado and San Francisco. The firm was acquired by Broadpoint Securities Group, Inc. (NASDAQ: BPSG) in 2008. Broadpoint.Am Tech seeks to generate profitable ideas through fundamental research. They offer timely and focused research on the information technology, clean energy and defense sectors for institutional investors including mutual funds and alternative asset managers. Broadpoint.AmTech covers the following industries: (1) aerospace and defense (2) analog semiconductors (3) broadband and media services (4) clean technology/biofuels (5) clean technology/energy generation and infrastructure (6) clean technology/coal (7) clean technology/solar (8) clean technology/wind (9) data networking and storage components (10) engineering and construction (11) financial technology (12) Internet (13) information technology hardware (13) LED industry (14) software (15) wireless communications and (16) wireless ICs.

Auriga USA is a broker/dealer located in New York City. Their research focuses on the semiconductors, information technology and health services sectors.

Auriga Capital Management LLC (ACM) is an asset management firm headquartered in New York City. The firm was founded in 2009 and is a subsidiary of F18Cm LLC. ACM provides personalized confidential investment management to institutional clients only. Such clients include banks or thrift institutions, investment companies, hedge funds, private funds, corporations or business entities.

Lirum Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the treatment of deliberating diseases. The firm is also involved in the acquisition, development, and commercialization of drug candidates. Its products include LX-101, a targeted therapy directed to the insulin-like growth factor 1 (IGF-1R). The company was founded in November 2021 and is headquartered in New York, NY.